Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Profluent Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Profluent Bio

Profluent Bio

Seed

Profluent Bio: An AI-driven firm specializing in designing innovative proteins for industry use.

HQ
Berkeley, CA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Profluent Bio, founded with a mission to revolutionize protein design through artificial intelligence, aims to overcome existing industrial barriers by creating novel and optimal proteins. The company leverages advanced AI technology to decode the complexities of protein structures, offering innovative solutions across various applications in biotechnology and pharmaceuticals.

Notable figures affiliated with Profluent Bio include leading experts in AI and biotechnology, although specific names are not disclosed. The company has made significant strides in the field, marked by its pioneering approach to protein design. Its impact is evident in the enhanced efficiency and effectiveness of industrial processes, setting new standards in the biotech industry.

Profluent Bio - Similar Companies

AI Proteins logo

AI Proteins

aiproteinstx.com

Diffuse Bio logo

Diffuse Bio

diffuse.bio

Manifold Bio logo

Manifold Bio

manifold.bio

Nabla Bio logo

Nabla Bio

nabla.bio

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

20n logo

20n

Adaptyv Biosystems logo

Adaptyv Biosystems

adaptyvbio.com

Proteinea logo

Proteinea

proteinea.com

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Evozyne logo

Evozyne

evozyne.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

BigHat Biosciences logo

BigHat Biosciences

bighatbio.com

Medium Biosciences logo

Medium Biosciences

medium.bio

BioMap logo

BioMap

biomap.com

A-Alpha Bio logo

A-Alpha Bio

aalphabio.com

Profluent Bio - Quick Facts

Who are Profluent Bio's competitors?

Companies similar to Profluent Bio include AI Proteins, Diffuse Bio, Manifold Bio and Nabla Bio.

When was Profluent Bio founded?

Profluent Bio was founded in 2022.

Where is Profluent Bio's headquarters located?

Profluent Bio's headquarters is located in Berkeley, CA, US.

When was Profluent Bio's last funding round?

Profluent Bio's most recent funding round was for $9M (USD) in August 2022.

How much has Profluent Bio raised to-date?

As of Aug 25, 2022, Profluent Bio has raised a total of $9M (USD).

How many employees does Profluent Bio have?

Profluent Bio has 4 employees as of Feb 5, 2024.

Profluent Bio - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Design
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software